HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Church & Dwight Takes Homeopathic Turn For OTC Sales Driver, Acquires Zicam Marketer Matrixx

Executive Summary

C&D CEO Matthew Farrell says Zicam has 73% share in the US zinc-containing wellness product market. It's acquiring marketer Matrixx Initiatives at a price almost 15 times Zicam brand’s projected 2021 EBITDA.

You may also be interested in...



Defend-Eeze Launches In US Zinc Cold Remedy Market

Vespyr, incorporated in December 2021 after operating as Nurya when it acquired Cold-Eeze from Mylan in May that year, offers Defend-Eeze in lozenges containing echinacea, elderberry and vitamins C and D3 in addition to zinc.

Church & Dwight ‘Left Money On Table’ In Q1, Same Supply Chain Problems Expected Q2 Before Easing

“We have the orders, we’re just struggling to fill them either due to production problems or transportation issues,” says CEO Matthew Farrell.

Church & Dwight Meets Supply, Inflation Headwinds With Line Extensions, Price Increases

C&D executives didn’t downplay potential challenges during 2022 – including an expected $155m increase in costs from inflation – as they discussed the health, personal and household care manufacturer and marketer’s 2021 full-year and fourth-quarter results and its long-range plans.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

RS150757

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel